Jerome Deval

VP, Discovery Biology

Professional Overview
Jerome Deval is an accomplished pharmaceutical executive with over 15 years of experience in the life sciences industry. As the Vice President of Discovery Biology at Bluejay Therapeutics, he leads a team of scientists in driving the discovery and development of novel therapeutic candidates. With his deep expertise in biochemistry, biophysics, and drug discovery, Jerome is focused on advancing cutting-edge therapeutic solutions to address unmet medical needs.

Experience Summary

Current Role
As the VP of Discovery Biology at Bluejay Therapeutics, Jerome is responsible for overseeing the company's early-stage drug discovery efforts. He leads a team of talented researchers in the identification and optimization of promising drug candidates, leveraging his extensive knowledge of target validation, assay development, and structure-based drug design. Under Jerome's leadership, Bluejay Therapeutics has made significant progress in advancing multiple drug candidates into clinical development, with a focus on rare and orphan diseases.

Career Progression
Prior to joining Bluejay Therapeutics, Jerome held senior roles at several leading biopharmaceutical companies. As the Senior Director of Biochemistry and Biophysics at Eikon Therapeutics, he spearheaded the development of innovative screening platforms and contributed to the advancement of the company's pipeline. Prior to that, he served as the Senior Director and Head of Biochemistry at Aligos Therapeutics, where he played a pivotal role in the discovery and optimization of novel small-molecule therapeutics. Earlier in his career, Jerome held scientific leadership positions at The Janssen Pharmaceutical Companies of Johnson & Johnson and Alios BioPharma, where he made significant contributions to drug discovery and development programs.

Academic Background
Jerome holds a Ph.D. in Biochemistry from the Centre National de la Recherche Scientifique (CNRS) in France. He completed his postdoctoral training at McGill University, where he further honed his expertise in protein structure, function, and drug design.

Areas of Expertise

• Drug discovery and development

• Target validation and assay development

• Biochemistry and biophysics

• Structure-based drug design

• Project management and scientific leadership

• Collaboration and cross-functional team building

Professional Impact
Throughout his career, Jerome has made substantial contributions to the advancement of novel therapeutics. He has authored numerous peer-reviewed publications and presented his work at prestigious scientific conferences. His work has led to the discovery and development of several drug candidates that have progressed into clinical trials, addressing unmet needs in rare diseases and various therapeutic areas.

Conclusion
With his extensive experience, technical expertise, and proven track record of success, Jerome Deval is a valuable asset to the Bluejay Therapeutics team. As the VP of Discovery Biology, he continues to drive innovation and push the boundaries of what is possible in the field of pharmaceutical research and development.